Curevac N V Net Income per Employee (CVAC), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Curevac N v   (NASDAQ: CVAC)
 

Curevac N V Net Income per Employee

CVAC's Quarterly Results, Trends, Rankings, Statistics
Curevac N V 's Income per employee grew in the second quarter 2025 on a trailing twelve month basis to $ 561,538, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 19 other companies achieving higher income per employee. While Curevac N V 's total ranking has deteriorated compared to the previous quarter from to 373.


What is Income per Employee Ratio?






CVAC Net Income per Employee (Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
0
III. Quarter
0
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 561,538 533,028 474,284 333,243 -813,746
CVAC's Total Ranking # 373 # # # # 4625
Seq. Net Income Change - - - - -


CVAC Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 20
Healthcare Sector # 34
Overall Market # 373

Net Income per Employee Statistics
High Average Low
$ 490,941 $ -335,202 $ -787,533
(Dec 31 2024)   (Dec 31 2023)







Companies with similar Income per Employee for 12 month ending Jun 30 2025, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2025Number of Employees Jun 30 2025
Illumina Inc   982,031.25 $ 1,257.000  Million 1,280 
Biomx Inc  928,350.00 $ 18.567  Million 20 
United Therapeutics Corporation  887,214.29 $ 1,242.100  Million 1,400 
Prestige Consumer Healthcare Inc   878,168.42 $ 500.556  Million 570 
Cytomx Therapeutics Inc   695,405.80 $ 47.983  Million 69 
Black Diamond Therapeutics Inc   687,571.43 $ 14.439  Million 21 
Ptc Therapeutics inc   634,886.98 $ 629.173  Million 991 
Harmony Biosciences Holdings inc   617,419.80 $ 180.904  Million 293 
Novavax inc   564,518.02 $ 422.824  Million 749 
Rigel Pharmaceuticals Inc  562,189.66 $ 97.821  Million 174 
Engene Therapeutics Inc   525,500.00 $ 43.091  Million 82 
Amgen Inc   509,153.85 $ 6,619.000  Million 13,000 
Krystal Biotech Inc   497,372.88 $ 146.725  Million 295 
Nutriband Inc   483,137.20 $ 2.416  Million
Aurinia Pharmaceuticals Inc   473,718.75 $ 60.636  Million 128 
Eledon Pharmaceuticals Inc   469,606.06 $ 15.497  Million 33 
Black Hawk Acquisition Corporation  433,992.50 $ 0.868  Million
Atara Biotherapeutics Inc   413,928.57 $ 5.795  Million 14 
Protagonist Therapeutics inc   394,227.27 $ 52.038  Million 132 
Gilead Sciences Inc   371,235.29 $ 6,311.000  Million 17,000 
Adma Biologics Inc   322,918.08 $ 208.928  Million 647 
Stoke Therapeutics Inc   308,729.41 $ 52.484  Million 170 
Incyte Corporation  306,213.08 $ 870.870  Million 2,844 
Regeneron Pharmaceuticals Inc   289,331.60 $ 4,458.600  Million 15,410 


Date modified: 2026-09-18T16:09:18+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.